Augmedix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.57	14.4	1.02	0.68	2.08
Short-Term Investments	12.32	2.37	2.59	-	-
Cash & Short-Term Investments	14.89	16.77	3.62	0.68	2.08
Cash Growth	175.47%	363.47%	432.14%	-67.29%	-
Receivables	0	-	0	-	-
Prepaid Expenses	0.27	0.06	0.03	0	-
Other Current Assets	-	-	-	0.2	-
Total Current Assets	15.17	16.83	3.64	0.88	2.08
Other Intangible Assets	0.94	0.2	0.05	0.06	-
Other Long-Term Assets	0	0	0	-	-
Total Assets	16.1	17.02	3.7	0.94	2.08
Accounts Payable	0.32	0.34	0.22	0.25	0.01
Accrued Expenses	0.18	0.06	0.05	0.01	0
Current Unearned Revenue	0	0	-	-	-
Total Current Liabilities	0.5	0.4	0.27	0.26	0.01
Total Liabilities	0.5	0.4	0.27	0.26	0.01
Common Stock	0	0	0	0	0
Additional Paid-In Capital	25.7	25.42	8.71	2.12	2.12
Retained Earnings	-9.99	-8.8	-5.38	-1.43	-0.01
Comprehensive Income & Other	-0.06	0.01	0.1	-	-0.04
Total Common Equity	15.65	16.63	3.43	0.69	2.07
Minority Interest	-0.05	-0.01	-	-	-
Shareholders' Equity	15.6	16.62	3.43	0.69	2.07
Total Liabilities & Equity	16.1	17.02	3.7	0.94	2.08
Net Cash (Debt)	14.89	16.77	3.62	0.68	2.08
Net Cash Growth	175.47%	363.47%	432.14%	-67.29%	-
Net Cash Per Share	4.54	9.43	3.66	0.78	2.77
Filing Date Shares Outstanding	7.12	7.12	1.09	1.01	0.87
Total Common Shares Outstanding	7.12	6.92	0.99	0.87	0.87
Working Capital	14.67	16.43	3.37	0.63	2.07
Book Value Per Share	2.20	2.40	3.47	0.79	2.38
Tangible Book Value	14.71	16.43	3.37	0.63	2.07
Tangible Book Value Per Share	2.07	2.37	3.41	0.72	2.38

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q